The board of directors of diaMentis reluctantly took the decision last Friday evening, February 24, 2023, to carry out a temporary collective layoff, including the entire management, taking effect this morning for an indefinite period.
writes company president Bernard Guimont in a statement sent Monday afternoon.
A total of 29 employees were laid off. According to Mr. Guimont, these are engineers, psychiatrists, neuroscientists, biostatisticians and mathematicians.
DiaMentis is developing a technology that would make it possible to diagnose certain mental health disorders through retinal analysis. The company is trying to get its technology approved by the United States Medicines Agency, the FDA. It was in the hope of obtaining this approval that she would have proceeded with this dismissal.
Diamentis began a refinancing phase last December. This refinancing phase is being actively maintained in order to support the continuation of ongoing work at the FDA
specifies Bernard Guimont.
Founded in 2015, Diamentis received $1M in aid from Ottawa in 2021.
In a statement sent last September, the company still aimed to commercialize its technology in North America by the end of 2024.